The top amount of exits for fund were in 2016. Deals in the range of 10 - 50 millions dollars are the general things for fund. Comparing to the other companies, this Eminent Venture Capital performs on 4 percentage points more the average number of lead investments. The important activity for fund was in 2007. The fund is constantly included in less than 2 deals per year.
The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the Eminent Venture Capital, startups are often financed by WI Harper Group, Sycamore Ventures, NanoDimension. The meaningful sponsors for the fund in investment in the same round are NanoDimension, Flagship Pioneering, RUSNANO. In the next rounds fund is usually obtained by Sycamore Ventures, PTV Healthcare Capital, Novo Holdings.
We can highlight the next thriving fund investment areas, such as Biopharma, Pharmaceutical. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Cardiva Medical, GlobeImmune, Nereus Pharmaceuticals The fund has no exact preference in some founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low.
Related Funds
| Fund Name | Location |
| AmTRAN Technology | Taipei, Taiwan |
| CB Health Ventures | Boston, Massachusetts, United States |
| CMU OFEF | Pennsylvania, Pittsburgh, United States |
| D2C Inc. | - |
| Encovox | - |
| Fabick CAT | Fenton, Missouri, United States |
| Financial Information Technologies (Fintech) | Florida, Tampa, United States |
| Galera Angels | Missouri, St Louis, United States |
| Global Asia Partners | Central, Central Region, Singapore |
| Holley Group | China, Hangzhou, Zhejiang |
| Jia Zhong Guang Li Touzi | Beijing, Beijing, China |
| Kickstarter | Brooklyn, New York, United States |
| Konsortium | Bayern, Germany, Gersthofen |
| LSL Property Services | Australia, New South Wales, Newcastle |
| Mengyun Yiruan | China, Shanghai |
| Qmangel Investment Partnership | Beijing, Beijing, China |
| Socogame | China, Shanghai |
| Wesfarmers | Australia, Perth, Western Australia |
| Yitu Technology | China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Tarveda Therapeutics | $21M | 07 Jan 2015 | Massachusetts, United States | ||
GlobeImmune | $41M | 26 Sep 2007 | Colorado, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Tarveda Therapeutics | $21M | 07 Jan 2015 | Massachusetts, United States | ||
GlobeImmune | $41M | 26 Sep 2007 | Colorado, United States |
